Home ⟩ Insights

Insights

interview

3 min read • June 19, 2025

EXCLUSIVE: Aurora Cannabis CEO Responds To Big Tobacco Concerns — It’s Not That Kind Of Partnership

4 min read • June 18, 2025

EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story

7 min read • May 20, 2025

Modelo Got It Right, Cannabis Didn’t, Says Latina CEO Who Built A Multi-State Business With $10K

8 min read • April 21, 2025

Marlon Wayans Talks Selling Weed On The Blockchain: Is Dr. Green Legit? He Isn’t Afraid To Answer The Tough Questions

3 min read • February 26, 2025

First Cannabis Products Franchise In South America Could Soon Land in The US: Meet Paraguay’s Cannashop

7 min read • February 17, 2025

EXCLUSIVE: Ex-Rep. Kinzinger On GOP’s Internal War Over Drug Policy, Cannabis, Psychedelics – ‘Quite Likely Legal In 5-10 Years’

3 min read • February 14, 2025

THC-Infused Coffee Pods? House Of Kush Blends Cannabis & Caffeine For The Ultimate Wake & Bake

7 min read • February 5, 2025

Cannabis Takes On Superbugs: Could This New Drug ‘Change Infection Treatment Forever’?

8 min read • January 30, 2025

No Banks? No Problem: How One Company Is Fixing The Cannabis Industry’s Capital Bottleneck

5 min read • December 9, 2024

EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surge

4 min read • December 3, 2024

EXCLUSIVE: Why Cannabis Industry Workers And Employees Should Think About 401(k) Plans

6 min read • December 2, 2024

Beyond The CBD Bubble: Can Hemp Fiber Boost US Manufacturing With Eco-Friendly Products?

Latest Headlines

3 min read • October 16, 2026

Inside Cronos’ 58% Revenue Growth: Market Share and Expansion

3 min read • October 15, 2026

DEA Cannabis Rescheduling Faces New October 21 Deadline After Judge Weighs Reopening Hearing

2 min read • October 15, 2026

Glass House Eyes European Cannabis Exports After GACP Certification

2 min read • October 15, 2026

“Curaleaf’s Revised Offer Still Does Not Reflect the Value”: Aurora Rejects $5 Hostile Bid

6 min read • October 15, 2026

Organigram Wants More Than Revenue From Germany. It Wants the Whole Margin

5 min read • October 14, 2026

The Real Cost of a Cannabis Gummy: Azuca’s CEO on Manufacturing Margins and Scale

5 min read • October 14, 2026

Cannabis Products Have to Earn Their Shelf Space. Curio Wellness Explains How

min read • October 13, 2026

Cronos Has a $1 Billion War Chest. Zuanic Sees Up to 3x Upside

5 min read • October 13, 2026

Marijuana Rescheduling Hits a New Deadline Today, With Court Fight Stretching Into 2027

4 min read • October 9, 2026

Vireo Secures $60 Million at 8.5% to Refinance Cannabis Facilities in New York and Florida

6 min read • October 9, 2026

“This Defies All Fiduciary Logic”: Curaleaf Fires Back at Aurora; Rival Deal Rumors Swirl

4 min read • October 9, 2026

Aurora Doubles German Cannabis Output, Giving Investors More to Weigh in Curaleaf Takeover

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

(opens in a new tab)